nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulpiride—DRD2—Signaling Pathways—PLCB2—prostate cancer	0.000201	0.000201	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LRP2—prostate cancer	0.000201	0.000201	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	0.000201	0.000201	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—MMP2—prostate cancer	0.000201	0.000201	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP3A4—prostate cancer	0.0002	0.0002	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	0.000199	0.000199	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ADRB2—prostate cancer	0.000198	0.000198	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—THBS1—prostate cancer	0.000198	0.000198	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PPP3CA—prostate cancer	0.000198	0.000198	CbGpPWpGaD
Sulpiride—CA9—Metabolism—INS—prostate cancer	0.000197	0.000197	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CX3CL1—prostate cancer	0.000197	0.000197	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—P4HB—prostate cancer	0.000197	0.000197	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP1B1—prostate cancer	0.000197	0.000197	CbGpPWpGaD
Sulpiride—DRD2—Circadian rythm related genes—IL6—prostate cancer	0.000196	0.000196	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ANXA1—prostate cancer	0.000195	0.000195	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—VAV3—prostate cancer	0.000194	0.000194	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HIST1H2BG—prostate cancer	0.000193	0.000193	CbGpPWpGaD
Sulpiride—CA9—Metabolism—CREBBP—prostate cancer	0.000193	0.000193	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GRB7—prostate cancer	0.000192	0.000192	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PDE4D—prostate cancer	0.000192	0.000192	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PRKCZ—prostate cancer	0.000192	0.000192	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GGT1—prostate cancer	0.00019	0.00019	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PIK3CB—prostate cancer	0.000189	0.000189	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—ITPR1—prostate cancer	0.000188	0.000188	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PTGS2—prostate cancer	0.000188	0.000188	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—NCOA1—prostate cancer	0.000187	0.000187	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PIK3CG—prostate cancer	0.000187	0.000187	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HIST1H4H—prostate cancer	0.000187	0.000187	CbGpPWpGaD
Sulpiride—DRD2—GPCR ligand binding—CXCL8—prostate cancer	0.000187	0.000187	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FGFR4—prostate cancer	0.000185	0.000185	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PARP1—prostate cancer	0.000185	0.000185	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP19A1—prostate cancer	0.000185	0.000185	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PIK3CD—prostate cancer	0.000183	0.000183	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CALCA—prostate cancer	0.000183	0.000183	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GNG5—prostate cancer	0.000182	0.000182	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CXCL12—prostate cancer	0.000179	0.000179	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—RXRA—prostate cancer	0.000178	0.000178	CbGpPWpGaD
Sulpiride—CA6—Metabolism—PIK3CA—prostate cancer	0.000175	0.000175	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	0.000173	0.000173	CbGpPWpGaD
Sulpiride—CA9—Metabolism—NOS3—prostate cancer	0.000173	0.000173	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—COMT—prostate cancer	0.000172	0.000172	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GSTP1—prostate cancer	0.000171	0.000171	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PIK3CG—prostate cancer	0.00017	0.00017	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ITPR1—prostate cancer	0.000168	0.000168	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CASP9—prostate cancer	0.000168	0.000168	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—CXCL8—prostate cancer	0.000167	0.000167	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—EP300—prostate cancer	0.000165	0.000165	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PIK3CD—prostate cancer	0.000165	0.000165	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PTEN—prostate cancer	0.000164	0.000164	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PRKCQ—prostate cancer	0.000163	0.000163	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NGFR—prostate cancer	0.000163	0.000163	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MAP3K7—prostate cancer	0.000161	0.000161	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PIK3CB—prostate cancer	0.00016	0.00016	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—TYMS—prostate cancer	0.000159	0.000159	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTHLH—prostate cancer	0.000159	0.000159	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TGFBR1—prostate cancer	0.000159	0.000159	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PTGS2—prostate cancer	0.000158	0.000158	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—GSTM1—prostate cancer	0.000157	0.000157	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AKR1C3—prostate cancer	0.000156	0.000156	CbGpPWpGaD
Sulpiride—CA2—Metabolism—EP300—prostate cancer	0.000156	0.000156	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PRKACB—prostate cancer	0.000155	0.000155	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FGF10—prostate cancer	0.000155	0.000155	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—LPL—prostate cancer	0.000154	0.000154	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of proteins—CTNNB1—prostate cancer	0.000154	0.000154	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ADRB2—prostate cancer	0.000153	0.000153	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—THBS1—prostate cancer	0.000152	0.000152	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PPP3CA—prostate cancer	0.000152	0.000152	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—JAK2—prostate cancer	0.000151	0.000151	CbGpPWpGaD
Sulpiride—CA12—Metabolism—PIK3CA—prostate cancer	0.000151	0.000151	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—MAP2K1—prostate cancer	0.000151	0.000151	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PIK3CD—prostate cancer	0.00015	0.00015	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—VAV3—prostate cancer	0.000149	0.000149	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ANXA1—prostate cancer	0.000149	0.000149	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CYP1A1—prostate cancer	0.000149	0.000149	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—ERCC2—prostate cancer	0.000148	0.000148	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TGFBR2—prostate cancer	0.000147	0.000147	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PRKCZ—prostate cancer	0.000147	0.000147	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ITPR1—prostate cancer	0.000145	0.000145	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PIK3CB—prostate cancer	0.000144	0.000144	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PIK3CG—prostate cancer	0.000143	0.000143	CbGpPWpGaD
Sulpiride—CA6—Metabolism—AKT1—prostate cancer	0.000143	0.000143	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PARP1—prostate cancer	0.000142	0.000142	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FGFR4—prostate cancer	0.000142	0.000142	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CALCA—prostate cancer	0.00014	0.00014	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—MTHFR—prostate cancer	0.000139	0.000139	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IGF1R—prostate cancer	0.000139	0.000139	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PTEN—prostate cancer	0.000138	0.000138	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—CXCL8—prostate cancer	0.000138	0.000138	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—JAK2—prostate cancer	0.000137	0.000137	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CXCL12—prostate cancer	0.000137	0.000137	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PPARA—prostate cancer	0.000136	0.000136	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—LPL—prostate cancer	0.000133	0.000133	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—IL2—prostate cancer	0.000132	0.000132	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PDGFRB—prostate cancer	0.000132	0.000132	CbGpPWpGaD
Sulpiride—CA9—Metabolism—EP300—prostate cancer	0.000132	0.000132	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PIK3CB—prostate cancer	0.00013	0.00013	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PIK3CG—prostate cancer	0.00013	0.00013	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CASP9—prostate cancer	0.000129	0.000129	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ITGB3—prostate cancer	0.000128	0.000128	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CAV1—prostate cancer	0.000128	0.000128	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PIK3CD—prostate cancer	0.000126	0.000126	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—CXCL8—prostate cancer	0.000125	0.000125	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PRKCQ—prostate cancer	0.000125	0.000125	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NGFR—prostate cancer	0.000125	0.000125	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ERBB3—prostate cancer	0.000124	0.000124	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FGFR2—prostate cancer	0.000124	0.000124	CbGpPWpGaD
Sulpiride—CA12—Metabolism—AKT1—prostate cancer	0.000123	0.000123	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MAP3K7—prostate cancer	0.000123	0.000123	CbGpPWpGaD
Sulpiride—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	0.000122	0.000122	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—IL2—prostate cancer	0.00012	0.00012	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TERT—prostate cancer	0.000119	0.000119	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FGF10—prostate cancer	0.000118	0.000118	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ADRB2—prostate cancer	0.000117	0.000117	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PIK3CG—prostate cancer	0.000117	0.000117	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—JAK2—prostate cancer	0.000116	0.000116	CbGpPWpGaD
Sulpiride—CA2—Metabolism—PIK3CA—prostate cancer	0.000115	0.000115	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—MAP2K1—prostate cancer	0.000115	0.000115	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PIK3CD—prostate cancer	0.000114	0.000114	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—VAV3—prostate cancer	0.000114	0.000114	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—HIF1A—prostate cancer	0.000114	0.000114	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TGFBR2—prostate cancer	0.000113	0.000113	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—LEP—prostate cancer	0.000111	0.000111	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ITPR1—prostate cancer	0.000111	0.000111	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—INS—prostate cancer	0.00011	0.00011	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CAV1—prostate cancer	0.00011	0.00011	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PIK3CB—prostate cancer	0.00011	0.00011	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—KDR—prostate cancer	0.000109	0.000109	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—CREBBP—prostate cancer	0.000108	0.000108	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ESR1—prostate cancer	0.000106	0.000106	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IGF1R—prostate cancer	0.000106	0.000106	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—CXCL8—prostate cancer	0.000106	0.000106	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—JAK2—prostate cancer	0.000105	0.000105	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—BAD—prostate cancer	0.000104	0.000104	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PIK3CD—prostate cancer	0.000103	0.000103	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LPL—prostate cancer	0.000102	0.000102	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—IL2—prostate cancer	0.000101	0.000101	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PDGFRB—prostate cancer	0.000101	0.000101	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PIK3CG—prostate cancer	0.0001	0.0001	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—APC—prostate cancer	0.0001	0.0001	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PIK3CB—prostate cancer	9.97e-05	9.97e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—EGF—prostate cancer	9.93e-05	9.93e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IRS1—prostate cancer	9.93e-05	9.93e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ITGB3—prostate cancer	9.82e-05	9.82e-05	CbGpPWpGaD
Sulpiride—CA9—Metabolism—PIK3CA—prostate cancer	9.73e-05	9.73e-05	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—NOS3—prostate cancer	9.68e-05	9.68e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—GSK3B—prostate cancer	9.64e-05	9.64e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—CXCL8—prostate cancer	9.58e-05	9.58e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ERBB3—prostate cancer	9.52e-05	9.52e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—INS—prostate cancer	9.51e-05	9.51e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FGFR2—prostate cancer	9.51e-05	9.51e-05	CbGpPWpGaD
Sulpiride—CA2—Metabolism—AKT1—prostate cancer	9.43e-05	9.43e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CREBBP—prostate cancer	9.32e-05	9.32e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IGF1—prostate cancer	9.2e-05	9.2e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—IL2—prostate cancer	9.16e-05	9.16e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—EGFR—prostate cancer	9.15e-05	9.15e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TERT—prostate cancer	9.13e-05	9.13e-05	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PIK3CB—prostate cancer	8.94e-05	8.94e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MAP2K1—prostate cancer	8.89e-05	8.89e-05	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PTGS2—prostate cancer	8.86e-05	8.86e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PIK3CD—prostate cancer	8.83e-05	8.83e-05	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—PIK3CA—prostate cancer	8.75e-05	8.75e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—SERPINE1—prostate cancer	8.74e-05	8.74e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—HIF1A—prostate cancer	8.73e-05	8.73e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—KRAS—prostate cancer	8.65e-05	8.65e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—LEP—prostate cancer	8.52e-05	8.52e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—FGF2—prostate cancer	8.46e-05	8.46e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CAV1—prostate cancer	8.44e-05	8.44e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—KDR—prostate cancer	8.35e-05	8.35e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—NOS3—prostate cancer	8.34e-05	8.34e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ESR1—prostate cancer	8.13e-05	8.13e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—JAK2—prostate cancer	8.11e-05	8.11e-05	CbGpPWpGaD
Sulpiride—CA9—Metabolism—AKT1—prostate cancer	7.95e-05	7.95e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—PIK3CA—prostate cancer	7.95e-05	7.95e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—BAD—prostate cancer	7.94e-05	7.94e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MDM2—prostate cancer	7.91e-05	7.91e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—ERBB2—prostate cancer	7.8e-05	7.8e-05	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PTEN—prostate cancer	7.72e-05	7.72e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PIK3CB—prostate cancer	7.7e-05	7.7e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—APC—prostate cancer	7.69e-05	7.69e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PIK3CG—prostate cancer	7.69e-05	7.69e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IRS1—prostate cancer	7.6e-05	7.6e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—EGF—prostate cancer	7.6e-05	7.6e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CXCL8—prostate cancer	7.4e-05	7.4e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—GSK3B—prostate cancer	7.38e-05	7.38e-05	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—EP300—prostate cancer	7.37e-05	7.37e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—INS—prostate cancer	7.28e-05	7.28e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CDKN1B—prostate cancer	7.23e-05	7.23e-05	CbGpPWpGaD
Sulpiride—DRD3—GPCR downstream signaling—AKT1—prostate cancer	7.15e-05	7.15e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CREBBP—prostate cancer	7.13e-05	7.13e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CASP3—prostate cancer	7.08e-05	7.08e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IL2—prostate cancer	7.07e-05	7.07e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IGF1—prostate cancer	7.04e-05	7.04e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—IL6—prostate cancer	7.04e-05	7.04e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—EGFR—prostate cancer	7e-05	7e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CCND1—prostate cancer	6.89e-05	6.89e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CTNNB1—prostate cancer	6.83e-05	6.83e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MAP2K1—prostate cancer	6.8e-05	6.8e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PIK3CD—prostate cancer	6.76e-05	6.76e-05	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—PIK3CA—prostate cancer	6.69e-05	6.69e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MMP9—prostate cancer	6.69e-05	6.69e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SERPINE1—prostate cancer	6.69e-05	6.69e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—CDKN1A—prostate cancer	6.67e-05	6.67e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PTEN—prostate cancer	6.65e-05	6.65e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—KRAS—prostate cancer	6.62e-05	6.62e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling by GPCR—AKT1—prostate cancer	6.49e-05	6.49e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—FGF2—prostate cancer	6.47e-05	6.47e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—NOS3—prostate cancer	6.38e-05	6.38e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—EP300—prostate cancer	6.34e-05	6.34e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—JAK2—prostate cancer	6.2e-05	6.2e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—SRC—prostate cancer	6.17e-05	6.17e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—PIK3CA—prostate cancer	6.08e-05	6.08e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MDM2—prostate cancer	6.06e-05	6.06e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—VEGFA—prostate cancer	6.01e-05	6.01e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—ERBB2—prostate cancer	5.97e-05	5.97e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—STAT3—prostate cancer	5.95e-05	5.95e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PIK3CB—prostate cancer	5.89e-05	5.89e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CXCL8—prostate cancer	5.66e-05	5.66e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—MYC—prostate cancer	5.53e-05	5.53e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CDKN1B—prostate cancer	5.53e-05	5.53e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TGFB1—prostate cancer	5.52e-05	5.52e-05	CbGpPWpGaD
Sulpiride—DRD2—GPCR downstream signaling—AKT1—prostate cancer	5.47e-05	5.47e-05	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—PIK3CA—prostate cancer	5.45e-05	5.45e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CASP3—prostate cancer	5.42e-05	5.42e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IL2—prostate cancer	5.41e-05	5.41e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—EGFR—prostate cancer	5.41e-05	5.41e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—IL6—prostate cancer	5.38e-05	5.38e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CCND1—prostate cancer	5.27e-05	5.27e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CTNNB1—prostate cancer	5.22e-05	5.22e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MMP9—prostate cancer	5.12e-05	5.12e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—KRAS—prostate cancer	5.11e-05	5.11e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—CDKN1A—prostate cancer	5.1e-05	5.1e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PTEN—prostate cancer	5.09e-05	5.09e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling by GPCR—AKT1—prostate cancer	4.97e-05	4.97e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—EP300—prostate cancer	4.86e-05	4.86e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—SRC—prostate cancer	4.72e-05	4.72e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—PIK3CA—prostate cancer	4.69e-05	4.69e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—VEGFA—prostate cancer	4.6e-05	4.6e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—STAT3—prostate cancer	4.55e-05	4.55e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—TP53—prostate cancer	4.54e-05	4.54e-05	CbGpPWpGaD
Sulpiride—BCHE—Metabolism—AKT1—prostate cancer	4.45e-05	4.45e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—MYC—prostate cancer	4.23e-05	4.23e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TGFB1—prostate cancer	4.22e-05	4.22e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—IL6—prostate cancer	4.16e-05	4.16e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—EGFR—prostate cancer	4.14e-05	4.14e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—KRAS—prostate cancer	3.91e-05	3.91e-05	CbGpPWpGaD
Sulpiride—DRD3—Signaling Pathways—AKT1—prostate cancer	3.83e-05	3.83e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—PIK3CA—prostate cancer	3.59e-05	3.59e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—TP53—prostate cancer	3.47e-05	3.47e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—IL6—prostate cancer	3.18e-05	3.18e-05	CbGpPWpGaD
Sulpiride—DRD2—Signaling Pathways—AKT1—prostate cancer	2.93e-05	2.93e-05	CbGpPWpGaD
